Exelixis, Inc.

NasdaqGS:EXEL

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

🔍 Research & Consulting

Location

United States

Market Cap

USD 10.15 B

Share Price

USD 37.72

Avg Daily Volume

3,763,748

Change (1 day)

0.88%

Change (1 year)

38.83%

Change (YTD)

13.27%

Exelixis, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending July 04, 2025: 34.47%

Exelixis, Inc. EBIT Margin is 34.47% for the Trailing 12 Months (TTM) ending July 04, 2025, a 72.30% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Exelixis, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 28, 2024 was 20.00%, a 142.83% change year over year.
Exelixis, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was 8.24%, a -61.79% change year over year.
Exelixis, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending July 01, 2022 was 21.56%, a 149.03% change year over year.
Exelixis, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending July 02, 2021 was 8.66%, a -72.81% change year over year.